OMEICOS Therapeutics GmbH

Investors can't seem to get enough of biopharmaceutical companies developing drugs for non-alcoholic steatohepatitis (NASH), an indication with potentially millions of patients, no approved therapies

Dr. Gerrit Hauck has been appointed as chief technology officer and member of the management committee at Basilea Pharmaceutica Ltd. , effective May 1. He will succeed Dr. Günter Ditzinger who

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio

New At The Helm Company Changes ALLSOP , David To: Amicus Therapeutics Inc. , SVP, International (April) From: Biogen Idec, SVP, Europe & Canada Phone: 609-662-2000 ATHA , Cindy To: Atossa